• About
  • Subscribe
  • Advertise
  • Contact
Sunday, July 12, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

KeepSight reaches new milestone in preventing vision loss

by Helen Carter
June 12, 2026
in Diabetic eye disease, Eye disease, Federal Government, News, Ophthalmic organisations, Optometry networks
Reading Time: 3 mins read
A A
The Specsavers screening team at the National Diabetes Summit, are, from left, Melissa Chandler Klunder, Kathryn Launchbury, Acyel Al-Alosi, Duchesne Markham and Dr Joseph Paul. Image: Specsavers.

The Specsavers screening team at the National Diabetes Summit, are, from left, Melissa Chandler Klunder, Kathryn Launchbury, Acyel Al-Alosi, Duchesne Markham and Dr Joseph Paul. Image: Specsavers.

Share on FacebookShare on Twitter

More than 42% of Australians living with diabetes have been referred to the KeepSight program to protect their sight, a new report shows.

The updated KeepSight report shows the growing national impact of Australia’s diabetes eye health reminder program, with more than 640,000 people now registered and millions of reminders and eye checks helping to prevent avoidable vision loss.

The second edition of the report Unveiling the value of KeepSight, authored by Deloitte Access Economics, was launched at the National Diabetes Summit at Parliament House.

The nation’s leading diabetes experts and advocates gathered at the event to highlight the growing scale and impact of diabetes.

Supported by the Parliamentary Friends Group for the Prevention of Diabetes co-chairs, Marion Scrymgour MP and Melissa McIntosh MP, the summit featured a keynote address from Mark Butler MP, Minister for Health, Disability and Ageing.

Dr Mike Freelander MP, chair of the Standing Committee on Health, Aged Care and Disability, and Senator Anne Ruston, Shadow Minister for Health and Ageing, also addressed attendees.

The summit was a fitting platform to highlight the latest KeepSight data and impact of the program alongside critical conversations about prevention, health system sustainability and equity of care.

KeepSight provides people living with diabetes free reminders when they are due for a routine eye check. Diabetes is the leading cause of blindness in working-age adults with early detection and treatment the most effective way to prevent vision loss.

The program is delivered by Diabetes Australia in partnership with founding partner Specsavers, supported by the Federal Government.

Increased follow-ups

Diabetes Australia Group CEO Justine Cain said the milestone KeepSight report marked a step forward in protecting the sight of Australians living with diabetes.

“The latest KeepSight data reveals that participants are more likely to come back for a follow-up eye check, and they tend to return sooner,” she said. “That’s really important because 90% of vision loss is preventable, so when people get regular eye checks, they’re more likely to catch problems early.”

More than 42% of Australians living with diabetes have been referred to the program to protect their sight, Cain said.

“The scale of participation reflects the real-world impact of the initiative. Having over 640,000 people now registered with the program is a significant milestone,” she said.

“The benefits are being felt every day by people managing diabetes. This program is changing lives by supporting people with diabetes to proactively look after their eye health and prevent complications.

“We recognise the important role Specsavers has played in driving registrations from day one. Specsavers has committed to embedding diabetes eye checks into their service model and their optometrists have had a significant impact on growing the program,” she said.

Specsavers register patients daily

At the summit, Specsavers senior stakeholder and professional communications manager Duchesne Markham said the program continues to deliver measurable improvements in eye health behaviour.

“The collaboration between Specsavers and Diabetes Australia has driven strong outcomes across the sector,” Markham said.

“Specsavers has a large and united workforce of optometrists who believe in the program and register their patients to KeepSight every day. Nine out of every ten people with diabetes who sit in our testing chairs at Specsavers give consent and are registered with KeepSight.

“These results reflect an industry determined to ensure people with diabetes access the care they need.”

At the National Diabetes Summit, Specsavers provided both eye and hearing screening experiences for members of parliament and staffers. Specsavers said it was the first eye and ear combined screening in Australian Government.

 

 

 

Related Posts

Dry eye symptoms are highly influential in diagnosis and treatment. Image: WavebreakMediaMicro.

CPD: TFOS DEWS III – DEW and improved

by staff writer
July 10, 2026

At the completion of this article, the reader should… •  Understand the key updates introduced in TFOS DEWS III. • ...

UNSW has achieved a top ranking. Image: UNSW.

UNSW named No. 1 in world for optometry research excellence

by Staff Writer
July 9, 2026

The UNSW School of Optometry & Vision Science has been recognised as the world's leading optometry school for research excellence,...

Doctors have a key role to play in eye health, according to the RACGP. Image: Graphic PNG Grid/stock.adobe.com.

GPs key to preventing avoidable vision loss, says RACGP

by Rob Mitchell
July 8, 2026

The Royal Australian College of GPs (RACGP) is highlighting the vital role GPs play in protecting Australians’ sight, with the July...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited